Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Spirenze - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Spirenze

Approved

STANDARD

Spirenze

Maxtar Bio-Genics🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: a8858ecbeb2b1849
Company: Maxtar Bio-Genics
Type: Standard

Approval Details

Approval Id: a8858ecbeb2b1849
Drug Approval Philippines Name: Spirenze
Product Name: Spirenze
Registration Number: DRP-7361-08
Brand Name: Spirenze
Generic Name: Spironolactone
Dosage Form: Tablet
Dosage Strength: 50 mg
Manufacturer: Maxtar Bio-Genics
Importer: Pharmakon Biotec Inc
Distributor: Kodapharm Med Corp.
Issuance Date: 31 July 2023
Expiry Date: 04 October 2026
Classification: Prescription Drug (Rx)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

a8858ecbeb2b1849

Type

Standard

Back to Philippines FDA Approvals